Clinical trial · Observational
Individualized Follow-Up for Head and Neck Cancer
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This pilot study evaluates offering Head and Neck Cancer (HNC) patients a choice between standardized and individualized follow-up after HNC treatment. Following treatment, the patient will be educated about self-examination of the head and neck and which physical symptoms require a follow-up visit. After completing 1.5 years of uncomplicated guideline-prescribed follow-up, patients will be offered the option to switch to individualized follow-up through a tailored decision aid. Standardized follow-up entails continuing the guideline-prescribed follow-up schedule until five years after treatment. Individualized follow-up consists of follow-up visits based on symptoms and other needs at the patient's initiative. We hypothesize that giving patients the choice between standardized and individualized follow-up is feasible and saves costs while maintaining quality of life.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Head and Neck Cancer | Malignant Head and Neck Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (0)
Data not yet available
Design
Arms and outcomes
Arms (2)
- label
- Standardized follow-up
- description
- Participants who chose to continue guideline-prescribed, standardized follow-up one year after HNC treatment.
- label
- Individualized follow-up
- description
- Participants who chose to switch to individualized follow-up one year after HNC treatment. Follow-up visits will only be scheduled based on clinical symptoms and questions, initiated by the patient.
Primary outcomes (6)
- measure
- Follow-up decision
- timeFrame
- Baseline
- description
- The type of follow-up that was chosen (standardized or individualized) will be distracted from the electronical patient record.
- measure
- Demand - assessed by the reach
- timeFrame
- 1.5 years
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Malignant tumor of the head and neck * First primary HNC * Participant was treated with curative intent * Participant has completed one year of uncomplicated routine follow-up * Treating physician supports the possible choice for patient-led follow-up Exclusion Criteria: * Malignant tumors of salivary glands * Participant is cognitively impaired * Participant is unable to read or write in Dutch
References
Publications (1)
- DERIVEDvan de Weerd C, van Tol-Geerdink JJ, van den Broek GB, Kaanders JHAM, Marres HAM, Hermens RPMG, Takes RP. Individualised follow-up for head and neck cancer-design of a prospective cohort study to assess its feasibility. BMJ Open. 2022 Dec 29;12(12):e068750. doi: 10.1136/bmjopen-2022-068750. PMID 36581428